PaulA.VolberdingMD

PubMed

• 61 citations
  HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers
  Radwa Sharaf, Guinevere Q. Lee, Xiaoming Sun, Behzad Etemad, Layla M. Aboukhater
  The Journal of Clinical Investigation. 2018-08-31
• 33 citations
  Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals
  Zachary C. Rich, Carissa Chu, Jessica Mao, Kali Zhou, Weiping Cai
  BMC Public Health. 2016-09-20
• 126 citations
  The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies
  Golnaz Namazi, Jesse Fajnzylber, Evgenia Aga, Ronald J. Bosch, Edward P. Acosta
  The Journal of Infectious Diseases. 2018-11-05

Journal Articles

• The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Post-Treatment Controllers Identified from 14 Clinical Studies  
  Elizabeth Connick, Michael C Sneller, Jonathan Z Li, Paul Volberding, Daniel R Kuritzkes, Robert T Schooley, David Margolis, Daniel Skiest, John W Mellors, Ronald Mits..., The Journal of Infectious Diseases
• Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society- USA panel  
  Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yen..., JAMA, 1/21/2010
• HIV and premature aging: A field still in its infancy  
  Martin J, Volberding P, Ann Intern Med, 1/5/2010
• Antiretroviral therapy and management of HIV infection  
  Volberding PA, Deeks SG, Lancet, 1/3/2010
• Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment  
  Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C, Hirsch M, Vogler M, Martinez A, Little S, Connick E, AIDS, 1/24/2009
• Cohorts, trials, and evidence: expanding our confidence in guidelines for antiretroviral resistance testing  
  Volberding P, Ann Intern Med, 1/21/2009
• Part-time careers in academic internal medicine: a report from the association of specialty professors part-time careers task force on behalf of the alliance for acade...  
  Linzer M, Warde C, Alexander RW, Demarco DM, Haupt A, Hicks L, Kutner J, Mangione CM, Mechaber H, Rentz M, Riley J, Schuster B, Solomon GD, Volberding P, Ibrahim T, Acad Med, 1/1/2009
• Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel  
  Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA, JAMA, 1/6/2008
• Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1- infected US veterans (1992-2004)  
  Holodniy M, Hornberger J, Rapoport D, Robertus K, MaCurdy TE, Lopez J, Volberding P, Deyton L, J Acquir Immune Defic Syndr, 1/1/2007
• The impact of HIV on chronic kidney disease outcomes  
  Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM, Kidney Int, 1/1/2007
• Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel  
  Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman..., JAMA, 1/16/2006
• Current issues in antiretroviral therapy: a case-based approach Advanced Studies in Medicine  
  Volberding, PA, Johns Hopkins, 1/1/2006
• Anemia and HIV in the antiretroviral era: potential significance of testosterone  
  Behler C, Shade S, Gregory K, Abrams D, Volberding P, AIDS Res Hum Retroviruses, 1/1/2005
• Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons  
  Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C, N Engl J Med, 1/29/2004
• Anemia in HIV infection: clinical impact and evidence-based management strategies  
  Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M, Clin Infect Dis, 1/15/2004
• A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy  
  Lalezari JP, Eron JJ, Carlson M, Cohen C, DeJesus E, Arduino RC, Gallant JE, Volberding P, Murphy RL, Valentine F, Nelson EL, Sista PR, Dusek A, Kilby JM, AIDS, 1/28/2003
• Human immunodeficiency virus hematology  
  Volberding PA, Baker KR, Levine AM, Hematology (Am Soc Hematol Educ Program), 1/1/2003
• The pavia consensus statement  
  Volberding PA, Murphy RL, Barbaro G, Barbarini G, Bruno R, Cirelli A, Currie PF, Di Lorenzo G, Fantoni M, Filiced G, Galli M, Grisorio B, Moroni M, Recusani F, Sacchi ..., AIDS, 1/1/2003
• HIV therapy in 2003: consensus and controversy  
  Volberding PA, AIDS, 1/1/2003
• The impact of anemia on quality of life in human immunodeficiency virus-infected patients  
  Volberding P, J Infect Dis, 1/15/2002
• Introduction: the importance of identifying and treating complications of human immunodeficiency virus disease  
  Volberding P, Sullivan P, J Infect Dis, 1/15/2002
• The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41- mediated virus fusion, in HIV-infected adults  
  Kilby JM, Lalezari JP, Eron JJ, Carlson M, Cohen C, Arduino RC, Goodgame JC, Gallant JE, Volberding P, Murphy RL, Valentine F, Saag MS, Nelson EL, Sista PR, Dusek A, AIDS Res Hum Retroviruses, 1/1/2002
• Adherence, resistance, and timing: current issues in the use of new therapies  
  Volberding P, AIDS Read, 1/1/2002
• What can modeling tell us about the threat of antiviral drug resistance?  
  Blower S, Volberding P, Curr Opin Infect Dis, 1/1/2002
• Toward a definition of HIV expertise: a survey of experienced HIV physicians  
  Gerbert B, Moe JC, Saag MS, Benson CA, Jacobsen DM, Feraios A, Hill ME, Bronstone A, Caspers N, Volberding PA, AIDS Patient Care STDS, 1/1/2001
• Join now to see all

Books/Book Chapters

• Global HIV/AIDS Medicine 
  Volberding PSaunders2007
• Viral and Immunological Malignancies (Clinical Oncology Series) (Hardcover) 
  Volberding Ppmph usa2006
• Principles and Practice of Infectious Diseases: 
  Chapter: Malignancies in human immunodeficiency virus infection 
  Gates A, Trubowitz PR, Volberding PA, Garvoy MREditors: ): Mandell GL, Bennett JE, Dolin R.Churchill LivinstoneEdition 6th,2005
• Focus on Living: Portraits of Americans With HIV And AIDS (Paperback) 
  Volberding PUniversity of Massachusetts Press2003
• Antiviral Chemotherapy 5: New Directions for Clinical Applications and Research (Advances in Experimental Medicine and Biology) (v. 5) (Hardcover) 
  Volberding P, ed.Editors: Mills J, Volberding PA, Corey L.Springer1999
• The Medical Management of AIDS 
  Volberding P, ed.Editors: Sande MA, Volberding PA.W.B. Saunders, Philadelphia, PAEdition 6th,1999
• The San Francisco General Hospital Handbook of HIV Management: A Guide to the Practical Management of HIV-Infected Patients 
  Volberding PParthenon Publishing1999
• The AIDS Knowledge Base: A Textbook on HIV Disease from the University of California (Hardcover) 
  Volberding P, ed.Lippincott Williams & WilkinsEdition 3rd,1999
• The Medical Management of AIDS 
  Chapter: Antiretroviral therapy 
  Volberding PAEditors: Sande MA, Volberding PA.W.B. Saunders, Philadelphia, PA1997
• Antiviral Chemotherapy 4: New Directions for Clinical Application and Research (Advances in Experimental Medicine and Biology) 
  Volberding P, ed.Editors: Mills J, Volberding PA, Corey L.1996
• Antiviral Chemotherapy 4: New Directions for Clinical Application and Research 
  Chapter: Controversies in initiating antiretroviral therapy and in the use of combination therapies 
  Volberding PAEditors: Mills J, Volberding PA, Corey L.Plenum Press1996
• Management of the HIV- Infected Patient 
  Chapter: Antiretroviral drugs 
  Volberding PAEditors: Crowe S, Hoy J, Mills J.Cambridge University Press1996
• The Medical Management of AIDS 
  Volberding P, ed.Editors: Sande MA, Volberding PA.W.B. Saunders, Philadelphia, PA1994
• nfectious Diseases Clinics of North America: Management of the HIV- Infected Patient 
  Chapter: Perspectives on the use of antiretroviral drugs in the treatment of HIV infection 
  Volberding PAEditors: Crowe S, Mills J, Hoy J.Cambridge University Press1994
• The AIDS Knowledgebase: a textbook on HIV disease from the University of California, San Francisco & the San Francisco General Hospital 
  Volberding P, ed.Editors: Cohen PT, Sande MA, Volberding PA.Little, Brown & Co, Boston, MA1994
• AIDS and Public Policy Journal, AIDS Law and Litigation Reporter, AIDS Reference and Research Collection 
  Childress JF, Collins C, Osborn JE, Fox DM, Henderson D, Volberding PA, Yeide HEditors: Bayer R, Hummel RF, Collins CJ.AIDS Publications for Decision Makers and Professionals: University Publishing Group1990
• AIDS Clinical Review 1989 
  Volberding PA, Jacobson MAMarcel Dekker, New York, NY1989
• The AIDS Knowledgebase 
  Volberding P, ed.Editors: Cohen PT, Sande MA, Volberding PA.Medical Publishing Group, Waltham1989
• Immunity to Cancer II 
  Chapter: Treatment of AIDS and its attendant malignancies 
  Volberding PA, Kaplan LDEditors: Mitchell MS.Alan R. Liss1989
• The Medical Management of AIDS 
  Volberding P, ed.Editors: Sande MA, Volberding PA.W.B. Saunders, Philadelphia, PA1988
• AIDS Principles, Practices and Politics 
  Chapter: AIDS overview 
  Volberding PAEditors: Corless IB, Pittman-Lindeman M.1988
• Viral Hepatitis and Acquired Immunodeficiency Syndrome 
  Chapter: Overview of current knowledge 
  Volberding PAEditors: Villarejos VM.LA State University1988
• Human Retroviruses, Cancer and AIDS Approaches to Prevention and Therapy 
  Chapter: Issues in the development of antiviral treatment of HIV infection 
  Volberding PAEditors: Bolognesis D.Alan R. Liss, New York, NY1988
• The Medical Management of AIDS 
  Chapter: Caring for the patient with AIDS: an integrated approach 
  Volberding PAEditors: Sande MA, Volberding PA.W.B. Saunders, Philadelphia, PA1988
• Confronting AIDS Update 1988 
  Cooper T, Altman S, Baltimore D, Gebbie K, Hopkins DR, Prewitt K, Temin HM, Volberding PA, et alNational Academy Press, Washington, DC1988
• Join now to see all

Abstracts/Posters

• Role of Guidelines in HIV Therapy
  Volberding PA, IX Simposium Por Un Mundo Sin VIH, Barcelona, Spain, 1/1/2003
• HIV care delivery in the US
  Bartlett JG, Volberding PA, IDSA 36th Annual Meeting, Denver, CO, 1/1/1998
• Community patterns of care for HIV disease: clinical experience and medical specialty training make a difference
  Brosgart CL, Mitchell TF, Bacchetti P, Jones J, Kaplan J, Stephenson KE, Coleman RL, Dyner T, Volberding PA, Abrams DI, IDSA 36th Annual Meeting, Denver, CO, 1/1/1998
• Zidovudine in early asymptomatic HIV disease: a controlled trial in subjects with greater than 400 CD4+ cells
  Volberding PA, Grimes J, Lagokos S, Stein D, 10th International Conference on AIDS, Yokohama, Japan, 1/1/1994
• Isolation and characterization of HIV from long term HIV positive asympotmatic individuals
  Feinberg M, Elbeik T, Sinclair E, Colbert D, Volberding PA, Buchbinder S, 9th International Conference on AIDS, Berlin, Germany, 1/1/1993
• Quantiation of plasma derived HIV-1 virion RNA using the HIV-1 branched DNA assay (bDNA)
  Bobey L, Saxer M, Kokka R, Feinberg M, Volberding PA, Elbeik T, 9th International Conference on AIDS, Berlin, Germany, 1/1/1993
• The effect of disease stage on the duration of zidovudine's effect. Oral presentation
  Volberding PA, Lagakos SW, Grimes JM, Stein DS, and the ACTG 019 Study Team, 9th International Conference on AIDS, Berlin, Germany, 1/1/1993
• The international state-of- the-art HIV clinical conference call series
  Jacobson MA, Arduino JM, Reddy M, Volberding PA, DeGrutolla V, et al, 9th International Conference on AIDS, Berlin, Germany, 1/1/1993
• The international state-of-the-art HIV clinical conference call series
  Macher A, Goosby E, Hoenig L, Pitchenik A, Clement M, Volberding PA, et al, 9th International Conference on AIDS, Berlin, Germany, 1/1/1993
• Educating primary care providers about HIV disease
  Macher A, Goosby E, Volbering PA, Goldschmidt, Brossier-Balano K, Williams A, Hoenig L, Gould B, Daniels E, 9th International Conference on AIDS, Berlin, Germany, 1/1/1993
• Degree of immunodeficiency at diagnosis of AIDS- associated non-Hodgkin's lymphoma
  Northfeld DW, Volberding PA, Kaplan LD, ASCO Annual Meeting, San Diego, CA, 1/1/1992
• A phase I study of recombinant human CD4 immunoglobulin G (rCD4-lgG) in patients with HIV-associated immune thrombocytopenic purpura
  Hassner, Arri C, Coleman R, Kaplan L, Volberding PA, 7th International Conference on AIDS, Florence, Italy, 1/1/1991
• Increasing CD8 counts predict subsequent development of intraoral lesions
  Melnick S, Hannan P, Decher L, Rhame FS, Little JW, Balfour HH, Volberding PA, 7th International Conference on AIDS, Florence, Italy, 1/1/1991
• Ifosfamide/etoposide for AIDS-related non- Hodgkin's lymphoma (AIDS-NHL)
  Northfelt DW, Kahn JO, Volberding PA, Kaplan LD, 7th International Conference on AIDS, Florence, Italy, 1/1/1991
• 2- chlorodeoxyadenosine (2-CDA) for AIDS-associated non-hodgkin's lymphoma (NHL). A phrase 1 study
  Kahn J, Kaplan L, Northfelt D, Piro L, Beutler E, Carson D, Abrams D, Volberding PA, ASCO Annual Meeting, Houston, TX, 1/1/1991
• Novel combination chemotherapy for Hodgkin's disease (HD) in HIV-infected individuals
  Kaplan L, Kahn J, Northfelt D, Abrams D, Volberding PA, ASCO Annual Meeting, Houston, TX, 1/1/1991
• Oral manifestations of human immunodeficiency virus (HIV) infection
  Melnick S, Rhame F, Balfour H, Little J, Rhodus N, Merry J, Walker P, Miller C, Volberding PA, International Congress for Infectious Diseases, Montreal, 1/1/1990
• Phase II study of weekly alternating vincristine and vinblastine plus zidovudine for AIDS-associated Kaposi's sarcoma
  Kahn J, Kaplan L, Volberding PA, Proceedings of ASCO, 1/1/1990
• Zidovudine therapy of asymptomatic HIV infected persons with less than 500 CD4+ cells/mm3
  Volberding PA, Lagokos S, Koch M, Pettinelli C, Myers M, Booth D, 11th International Conference on AIDS, San Francisco, CA, 1/1/1990
• Serologic variables at diagnosis with Kaposi's sarcoma (KS): predictors of shortened survival
  Volberding PA, Feigal D, et al, 5th International Conference on AIDS, Montreal, 1/1/1989
• Triage system for potential research subjects into active AIDS clinical trials
  DeGenova V, Mills J, Holland R, Feigal D, Volberding PA, Nash M, 5th International Conference on AIDS, Montreal, 1/1/1989
• Personal AIDS-related behavior among participants to the Stockholm IV International Conference on AIDS
  Umberto T, Mazzocco D, Serraino D, Lazzarin A, Clumeck N, Volberding PA, Franceschi S, 5th International Conference on AIDS, Montreal, 1/1/1989
• Phase II trial on intralesional recominant tumor necrosis factor alpha (rTNR) for AIDS-associated Kaposi's sarcoma (KS)
  Kahn J, Kaplan L, Ziegler J, Volberding PA, Crowe S, Sachs, Abrams D, Proceedings of the American Society of Clinical Oncology, San Francisco, CA, 1/1/1989
• Effect of chemotherapy for HIV-associated Kaposi's sarcoma on longterm survival
  Volberding PA, Kusick P, Feigal DW, Proceedings of the American Society of Clinical Oncology, San Francisco, CA, 1/1/1989
• Clonality of AIDS-associated non-Hodgkin's lymphoma predicts survival
  Kaplan LD, Meeker T, Feigal E, Volberding PA, Herndier B, Khayam-Bashi F, Grimaldi C, McGrath MS, Clinical Research, Stockholm, 1/1/1989
• Join now to see all